The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Sumant Satchidanand Kulkarni - Canaccord Genuity Corp., Research Division - Analyst
: Can you hear me now? Sorry about that.
Question: Sumant Satchidanand Kulkarni - Canaccord Genuity Corp., Research Division - Analyst
: You had a very balanced take on some of your slides. So in that context, on slide 28, you had some key objections to adoption that were listed.
Could you share any quantitative metrics, perhaps average percentages of responders that expressed objections to adoption versus the metrics
for key drivers of adoption? And Will, are you -- could you care to comment on what potential peak sales might be for the product?
Question: Anita Dushyanth - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
: Great presentation. Just one for me. Remember, you mentioned earlier that as patients came in for treatment, there was a sort of cocktail of drugs
being given. Now with 501, how is that likely to change the protocol? And then what sort of language would be in the label to highlight the
differentiating aspect of 501?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
JUNE 25, 2021 / 4:00PM, BTAI.OQ - BioXcel Therapeutics Inc Commercial Day
Question: Anita Dushyanth - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
: Yes. So I was asking like how is the language in the label sort of would be presented to reflect the differentiating aspect of 501?
Question: Sumant Satchidanand Kulkarni - Canaccord Genuity Corp., Research Division - Analyst
: Thanks for the follow-up. For Dr. Zun specifically, if BXCL501 is approved, do you think this type of product real application lies in institutional
administration or at home use even before the patient comes in or is brought to the hospital?
| 
